Sarcoma (Jan 1999)

Hyperthermic Isolated Limb Perfusion with TNF α and Cisplatin in the Treatment of Osteosarcoma of the Extremities: A Feasibility Study in Healthy Dogs

  • Robert J. Van Ginkel,
  • Charles L. H. Van Berlo,
  • Peter C. Baas,
  • Heimen Schraffordt Koops,
  • Ries Van Groningen B. Stuling,
  • Jan Elstrodt,
  • Harald J. Hoekstra

DOI
https://doi.org/10.1080/13577149977703
Journal volume & issue
Vol. 3, no. 2
pp. 89 – 94

Abstract

Read online

Purpose. The feasibility of hyperthermic isolated limb perfusion (HILP) with tumor necrosis factor-α (TNFα ) and cisplatin for the management of osteosarcoma was studied in the canine model.